MoneyWorks4Me

Dr Reddys Laboratories informs about quarterly statement of investor complaints

14 Jul 2016 Evaluate

Dr Reddys Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1801.00
Dr. Reddys Labs. 1209.15
Cipla 1343.00
Lupin 2035.00
Zydus Lifesciences 1160.00
View more..